ESC Premium Access

Current treatment for elevated lipoprotein(a).

Congress Session

About the speaker

Professor Anne Carol Goldberg

The Washington University, Saint Louis (United States of America)
1 presentation
1 follower

3 more presentations in this session

Lipoprotein(a) and cardiovascular risk.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)


Future treatments for lipoprotein(a).

Speaker: Professor S. Nicholls (Melbourne, AU)


Lipoprotein(a): an emerging lipid risk factor – discussion.


Access the full session

Lipoprotein(a): an emerging lipid risk factor

Speakers: Professor A. Goldberg, Professor B. Nordestgaard, Professor S. Nicholls

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes

27 August 2021

ESC Premium Access

The novel ageing-induced long non-coding RNA MIRIAL controls endothelial cell and mitochondrial function

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk